|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
|
GB0009803D0
(en)
|
2000-04-25 |
2000-06-07 |
Astrazeneca Ab |
Chemical compounds
|
|
DE60125373T2
(de)
|
2000-07-26 |
2007-10-18 |
Smithkline Beecham P.L.C., Brentford |
Aminopiperidin chinoline und ihre azaisosteren analoga mit antibakterieller wirkung
|
|
EP1719770A3
(en)
*
|
2000-09-21 |
2008-03-05 |
Smithkline Beecham Plc |
Quinoline derivatives as antibacterials
|
|
GB0031086D0
(en)
*
|
2000-12-20 |
2001-01-31 |
Smithkline Beecham Plc |
Medicaments
|
|
GB0101577D0
(en)
|
2001-01-22 |
2001-03-07 |
Smithkline Beecham Plc |
Compounds
|
|
GB0112834D0
(en)
|
2001-05-25 |
2001-07-18 |
Smithkline Beecham Plc |
Medicaments
|
|
GB0112836D0
(en)
*
|
2001-05-25 |
2001-07-18 |
Smithkline Beecham Plc |
Medicaments
|
|
US6632810B2
(en)
*
|
2001-06-29 |
2003-10-14 |
Kowa Co., Ltd. |
Cyclic diamine compound with condensed-ring groups
|
|
ATE449090T1
(de)
*
|
2001-07-02 |
2009-12-15 |
High Point Pharmaceuticals Llc |
Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren
|
|
GB0118238D0
(en)
*
|
2001-07-26 |
2001-09-19 |
Smithkline Beecham Plc |
Medicaments
|
|
WO2003064431A2
(en)
|
2002-01-29 |
2003-08-07 |
Glaxo Group Limited |
Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
|
|
WO2003064421A1
(en)
|
2002-01-29 |
2003-08-07 |
Glaxo Group Limited |
Aminopiperidine derivatives
|
|
CN1172919C
(zh)
*
|
2002-06-03 |
2004-10-27 |
上海医药工业研究院 |
芳烷醇哌嗪衍生物及其在制备抗抑郁症药物中的应用
|
|
AR040335A1
(es)
|
2002-06-26 |
2005-03-30 |
Glaxo Group Ltd |
Compuesto de ciclohexano o ciclohexeno, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende, procedimiento y compuestos intermediarios de utilidad para preparar dicho compuesto
|
|
TW200409637A
(en)
|
2002-06-26 |
2004-06-16 |
Glaxo Group Ltd |
Compounds
|
|
GB0217294D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicaments
|
|
AU2003301414B8
(en)
*
|
2002-10-10 |
2010-06-17 |
Morphochem Aktiengesellschaft Fur Kombinatorische Chemie |
Novel compounds with antibacterial activity
|
|
DE60331849D1
(de)
|
2002-11-05 |
2010-05-06 |
Glaxosmithkline Llc |
Antibakterielle wirkstoffe
|
|
AU2003291227A1
(en)
|
2002-11-05 |
2004-06-07 |
Smithkline Beecham Corporation |
Antibacterial agents
|
|
WO2004050036A2
(en)
|
2002-12-04 |
2004-06-17 |
Glaxo Group Limited |
Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
|
|
TW200507841A
(en)
*
|
2003-03-27 |
2005-03-01 |
Glaxo Group Ltd |
Antibacterial agents
|
|
BRPI0413132A
(pt)
*
|
2003-07-31 |
2006-10-03 |
Irm Llc |
composições e compostos bicìclicos como inibidores de pdf
|
|
US20070161627A1
(en)
*
|
2004-08-09 |
2007-07-12 |
Miller William H |
Antibacterial agents
|
|
GB0428327D0
(en)
*
|
2004-12-24 |
2005-02-02 |
Astrazeneca Ab |
Method
|
|
KR20070091677A
(ko)
|
2004-12-24 |
2007-09-11 |
아스트라제네카 아베 |
Ｃｃｒ2ｂ 길항제로서의 헤테로시클릭 화합물
|
|
EP2937341B1
(en)
|
2004-12-30 |
2017-07-05 |
Janssen Pharmaceutica N.V. |
4-(benzyl)-piperazine-1-carboxylic acid phenylamide derivatives and related compounds as modulators of fatty acid amide hydrolase (faah) for the treatment of anxiety, pain and other conditions
|
|
WO2006081178A2
(en)
|
2005-01-25 |
2006-08-03 |
Glaxo Group Limited |
Antibacterial agents
|
|
WO2006081289A2
(en)
|
2005-01-25 |
2006-08-03 |
Glaxo Group Limited |
Antibacterial agents
|
|
WO2006081182A2
(en)
|
2005-01-25 |
2006-08-03 |
Glaxo Group Limited |
Antibacterial agents
|
|
US7605169B2
(en)
|
2005-01-25 |
2009-10-20 |
Glaxo Group Limited |
Antibacterial agents
|
|
WO2006081179A1
(en)
|
2005-01-25 |
2006-08-03 |
Glaxo Group Limited |
Antibacterial agents
|
|
EP1863483A4
(en)
|
2005-03-31 |
2010-03-31 |
Janssen Pharmaceutica Nv |
Bicyclic pyrazole compounds as anti-bacteriostatic agents
|
|
JP4902247B2
(ja)
*
|
2005-04-08 |
2012-03-21 |
富山化学工業株式会社 |
２−（１−ベンゾチオフェン−５−イル）エタノールの新規製造法およびその中間体
|
|
MY150958A
(en)
|
2005-06-16 |
2014-03-31 |
Astrazeneca Ab |
Compounds for the treatment of multi-drug resistant bacterial infections
|
|
EP1900732A4
(en)
|
2005-06-24 |
2009-11-18 |
Toyama Chemical Co Ltd |
NEW NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF
|
|
GB0525957D0
(en)
*
|
2005-12-21 |
2006-02-01 |
Astrazeneca Ab |
Methods
|
|
JP2009524643A
(ja)
|
2006-01-26 |
2009-07-02 |
アクテリオン ファーマシューティカルズ リミテッド |
テトラヒドロピラン抗生物質
|
|
EP1991540A1
(en)
*
|
2006-02-21 |
2008-11-19 |
Amgen Inc. |
Cinnoline derivatives as phosphodiesterase 10 inhibitors
|
|
EP1991531A1
(en)
*
|
2006-02-28 |
2008-11-19 |
Amgen Inc. |
Cinnoline and quinoxaline derivates as phosphodiesterase 10 inhibitors
|
|
CA2644850A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Amgen Inc. |
Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
|
|
EP2001887B1
(en)
|
2006-04-06 |
2010-09-15 |
Glaxo Group Limited |
Pyrrolo-quinoxalinone derivatives as antibacterials
|
|
EP2007377A4
(en)
|
2006-04-06 |
2011-08-17 |
Glaxo Group Ltd |
ANTIBACTERIAL ACTIVE SUBSTANCES
|
|
SG164384A1
(en)
|
2006-05-26 |
2010-09-29 |
Toyama Chemical Co Ltd |
Novel heterocyclic compound or salt thereof and intermediate thereof
|
|
GB0613208D0
(en)
|
2006-07-03 |
2006-08-09 |
Glaxo Group Ltd |
Compounds
|
|
EP1992628A1
(en)
|
2007-05-18 |
2008-11-19 |
Glaxo Group Limited |
Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
|
|
CA2684659C
(en)
*
|
2007-04-20 |
2015-11-24 |
Glaxo Group Limited |
Tricyclic nitrogen containing compounds as antibacterial agents
|
|
SI2221309T1
(sl)
|
2007-11-26 |
2013-10-30 |
Toyama Chemical Co., Ltd. |
Monohidrat derivata naftiridina
|
|
EP2080761A1
(en)
|
2008-01-18 |
2009-07-22 |
Glaxo Group Limited |
Compounds
|
|
WO2010043714A1
(en)
|
2008-10-17 |
2010-04-22 |
Glaxo Group Limited |
Tricyclic nitrogen compounds used as antibacterials
|
|
JP5653935B2
(ja)
|
2009-01-15 |
2015-01-14 |
グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ |
抗菌薬として有用なナフチリジン―２（１ｈ）−オン化合物
|
|
US8673920B2
(en)
|
2009-05-06 |
2014-03-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
US20120220603A1
(en)
*
|
2009-09-04 |
2012-08-30 |
Zalicus Pharmaceuticals Ltd. |
Substituted heterocyclic derivatives for the treatment of pain and epilepsy
|
|
EP2632465B1
(en)
|
2010-10-27 |
2015-12-30 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
US9056859B2
(en)
|
2010-10-29 |
2015-06-16 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
GB201106817D0
(en)
|
2011-04-21 |
2011-06-01 |
Astex Therapeutics Ltd |
New compound
|
|
EP2744499B1
(en)
|
2011-08-19 |
2016-09-28 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
US9527830B2
(en)
|
2011-09-16 |
2016-12-27 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
WO2013062892A1
(en)
|
2011-10-25 |
2013-05-02 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
WO2013062900A1
(en)
|
2011-10-25 |
2013-05-02 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
EP2773206B1
(en)
|
2011-10-31 |
2018-02-21 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
EP2773351B1
(en)
|
2011-10-31 |
2017-08-23 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
EP2773199B1
(en)
|
2011-10-31 |
2019-04-10 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
EP2790511B1
(en)
|
2011-12-16 |
2016-09-14 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
AR089929A1
(es)
|
2012-02-10 |
2014-10-01 |
Actelion Pharmaceuticals Ltd |
Proceso para manufacturar un derivado de naftiridina
|
|
AR092031A1
(es)
|
2012-07-26 |
2015-03-18 |
Merck Sharp & Dohme |
Inhibidores del canal de potasio medular externo renal
|
|
GB201218850D0
(en)
|
2012-10-19 |
2012-12-05 |
Astex Therapeutics Ltd |
Bicyclic heterocycle compounds and their uses in therapy
|
|
US9980973B2
(en)
|
2012-10-19 |
2018-05-29 |
Astex Therapeutics Limited |
Bicyclic heterocycle compounds and their uses in therapy
|
|
GB201218864D0
(en)
|
2012-10-19 |
2012-12-05 |
Astex Therapeutics Ltd |
Bicyclic heterocycle compounds and their uses in therapy
|
|
GB201218862D0
(en)
|
2012-10-19 |
2012-12-05 |
Astex Therapeutics Ltd |
Bicyclic heterocycle compounds and their uses in therapy
|
|
US9777002B2
(en)
|
2012-11-29 |
2017-10-03 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
US9573961B2
(en)
|
2012-12-19 |
2017-02-21 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
EP2956142B1
(en)
|
2013-02-18 |
2017-09-20 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
US10208023B2
(en)
|
2013-03-01 |
2019-02-19 |
Mark G. DeGiacomo |
Heterocyclic inhibitors of the sodium channel
|
|
US9765074B2
(en)
|
2013-03-15 |
2017-09-19 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
US9751881B2
(en)
|
2013-07-31 |
2017-09-05 |
Merck Sharp & Dohme Corp. |
Inhibitors of the renal outer medullary potassium channel
|
|
LT3083616T
(lt)
|
2013-12-20 |
2021-09-10 |
Astex Therapeutics Limited |
Bicikinių heterociklų junginiai ir jų panaudojimas terapijoje
|
|
EP3110799A4
(en)
*
|
2014-02-27 |
2017-10-11 |
Epirus Biopharmaceuticals, Inc. |
Heterocyclic inhibitors of the sodium channel
|
|
WO2016027249A1
(en)
|
2014-08-22 |
2016-02-25 |
Glaxosmithkline Intellectual Property Development Limited |
Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
|
|
WO2016127358A1
(en)
|
2015-02-12 |
2016-08-18 |
Merck Sharp & Dohme Corp. |
Inhibitors of renal outer medullary potassium channel
|
|
TW201722965A
(zh)
|
2015-08-16 |
2017-07-01 |
葛蘭素史密斯克藍智慧財產發展有限公司 |
用於抗菌應用之化合物
|
|
US11884647B2
(en)
|
2019-10-18 |
2024-01-30 |
The Regents Of The University Of California |
Compounds and methods for targeting pathogenic blood vessels
|